Business
Imaging3 Announces MoneyTV’s Interview of Scott Pancoast to Discuss the Company and its Prospects
Imaging3 Announces MoneyTV’s Interview of Scott Pancoast to Discuss the Company and its Prospects.
About this update from Grapefruit Usa Inc.
[{"type":"text","content":"\n\n BURBANK, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG) announced today that its special consultant, Scott Pancoast, will be interviewed on MoneyTV with host Donald Baillargeon to discuss Imaging3’s business and its prospects.\n MoneyTV is the internationally syndicated television program (http://www.moneytv.net) that features informative interviews with company CEOs, providing insights into their operations and outlooks for their futures. Mr. Baillargeon will focus on Imaging3’s recent financial restructurings and will delve into Scott Pancoast’s vision of what needs to be accomplished going forward. Dane Medley, president stated: “With Scott Pancoast’s leadership and negotiation skills, we have come a long way in a rapid time frame. We are now positioned to move the company forward without all the previous constraints.”  In addition to being televised, the program can also be viewed online at www.moneytv.net. To determine the station that airs MoneyTV in your area, please visit their website and click on the “Global TV Listings” tab. About Imaging3 Imaging3, Inc., founded in 1993, has developed a patented medical imaging technology, called SmartScan™, that will produce 3D x-ray images, virtually in real time. The SmartScan technology will allow healthcare professionals to perform diagnostic and therapeutic procedures more quickly and accurately, resulting in higher throughput for the clinicians and fewer safety risks for the patient. In addition, Imaging3’s technology exposes patients to significantly less harmful radiation than current imaging technologies such as CT scans, which the company believes will allow scans to be used in more pediatric applications than are currently prescribed. The technology also allows for greater portability, easier installation, and a significantly reduced cost burden for the healthcare system overall. Imaging3 is planning to submit a 510K application to the FDA during 2017 in order to gain approval to commercialize the SmartScan technology. Visit the company’s website at http://www.imaging3.com for detailed information about the Company’s technology. Safe Harbor Statement Imaging3 cautions you that any statement included in this press release that is not a description of historical facts is...